Elusiveness of cystic-fibrosis treatment.
Littlewood
J M
JM
Govan
J R
JR
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003550:Cystic Fibrosis / Q000150:complications*; D006801:Humans; D011552:Pseudomonas Infections / Q000150:complications / Q000188:drug therapy*
D000900:Anti-Bacterial Agents